• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Wanbury Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524212
INE107F01022
41.3428411
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
WANBURY
13.76
959.09
EPS(TTM)
Face Value()
Div & Yield %
19.95
10
0
 

Devyani International reports consolidated net loss of Rs 10.04 crore in the March 2026 quarter
May 15,2026
Net Loss of Devyani International reported to Rs 10.04 crore in the quarter ended March 2026 as against net loss of Rs 14.74 crore during the previous quarter ended March 2025. Sales rose 18.50% to Rs 1436.86 crore in the quarter ended March 2026 as against Rs 1212.59 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 38.63 crore in the year ended March 2026 as against net profit of Rs 9.15 crore during the previous year ended March 2025. Sales rose 13.34% to Rs 5611.48 crore in the year ended March 2026 as against Rs 4951.05 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1436.861212.59 18 5611.484951.05 13
OPM %15.3315.32 -15.1316.37 -
PBDT164.35129.43 27 618.61582.66 6
PBT-18.13-22.35 19 -35.3712.79 PL
NP-10.04-14.74 32 -38.639.15 PL